Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
Cell Adhesion
100%
Cutaneous T-cell Lymphoma
100%
Predictive Marker
100%
Inhibitor Resistance
100%
Migration Routes
100%
Histone Acetylation
33%
LAIR2
33%
Lymphoma Patients
25%
RNA Sequencing (RNA-seq)
16%
Gene Expression
16%
Patient Plasma
16%
Inhibitor Resistant
16%
T Cells
8%
Blood Samples
8%
Cancer Center
8%
Epigenetic Modifiers
8%
Peripheral Blood
8%
Microarray
8%
Molecular Markers
8%
C-X-C Chemokine Receptor Type 4 (CXCR4)
8%
Anti-apoptotic
8%
Clinical Decision-making
8%
Skin Biopsy
8%
Chromatin Immunoprecipitation (ChIP)
8%
Inhibitor Therapy
8%
Patient Cohort
8%
Redox
8%
Primary Cutaneous T-cell Lymphoma
8%
H3K14
8%
BIRC5
8%
Chromatin Acetylation
8%
RRM2
8%
Inhibitor Response
8%
GSTM1
8%
H3K27ac
8%
TXNDC5
8%
NCATS
8%
Neuroscience
T Cell
100%
Cell Adhesion
100%
Histone Deacetylase Inhibitor
100%
Histone Acetylation
28%
Gene Expression
14%
RNA-Seq
14%
Blood Plasma
14%
Cell Cycle
7%
CXCR4
7%
Clinical Decision Making
7%
ELISA
7%
Acetylation
7%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Cell Adhesion
100%
Histone Deacetylase
50%
Histone Acetylation
28%
Gene Expression
14%
RNA Sequencing
14%
Blood Plasma
14%
Epigenetics
7%
Cell Cycle
7%
Genetic Marker
7%
CXCR4
7%
Acetylation
7%
Clinical Decision Making
7%
RRM2
7%